These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 30647436)

  • 21. The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study.
    Faghihzadeh F; Adibi P; Hekmatdoost A
    Br J Nutr; 2015 Sep; 114(5):796-803. PubMed ID: 26234526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Mastiha supplementation on NAFLD: The MAST4HEALTH Randomised, Controlled Trial.
    Amerikanou C; Kanoni S; Kaliora AC; Barone A; Bjelan M; D'Auria G; Gioxari A; Gosalbes MJ; Mouchti S; Stathopoulou MG; Soriano B; Stojanoski S; Banerjee R; Halabalaki M; Mikropoulou EV; Kannt A; Lamont J; Llorens C; Marascio F; Marascio M; Roig FJ; Smyrnioudis I; Varlamis I; Visvikis-Siest S; Vukic M; Milic N; Medic-Stojanoska M; Cesarini L; Campolo J; Gastaldelli A; Deloukas P; Trivella MG; Francino MP; Dedoussis GV;
    Mol Nutr Food Res; 2021 May; 65(10):e2001178. PubMed ID: 33629536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synbiotic supplementation in lean patients with non-alcoholic fatty liver disease: a pilot, randomised, double-blind, placebo-controlled, clinical trial.
    Mofidi F; Poustchi H; Yari Z; Nourinayyer B; Merat S; Sharafkhah M; Malekzadeh R; Hekmatdoost A
    Br J Nutr; 2017 Mar; 117(5):662-668. PubMed ID: 28345499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomised trial of chronic supplementation with a nutraceutical mixture in subjects with non-alcoholic fatty liver disease.
    Cerletti C; Colucci M; Storto M; Semeraro F; Ammollo CT; Incampo F; Costanzo S; De Bartolomeo G; Portincasa P; Barone M; Di Castelnuovo A; Semeraro N; Iacoviello L; de Gaetano G
    Br J Nutr; 2020 Jan; 123(2):190-197. PubMed ID: 31554528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mass-Spectrometry-Based Serum Metabolomics of a C57BL/6J Mouse Model of High-Fat-Diet-Induced Non-alcoholic Fatty Liver Disease Development.
    Lai YS; Chen WC; Kuo TC; Ho CT; Kuo CH; Tseng YJ; Lu KH; Lin SH; Panyod S; Sheen LY
    J Agric Food Chem; 2015 Sep; 63(35):7873-84. PubMed ID: 26262841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A pilot study of the effects of chromium picolinate supplementation on serum fetuin-A, metabolic and inflammatory factors in patients with nonalcoholic fatty liver disease: A double-blind, placebo-controlled trial.
    Moradi F; Kooshki F; Nokhostin F; Khoshbaten M; Bazyar H; Pourghassem Gargari B
    J Trace Elem Med Biol; 2021 Jan; 63():126659. PubMed ID: 33045675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
    Barchetta I; Del Ben M; Angelico F; Di Martino M; Fraioli A; La Torre G; Saulle R; Perri L; Morini S; Tiberti C; Bertoccini L; Cimini FA; Panimolle F; Catalano C; Baroni MG; Cavallo MG
    BMC Med; 2016 Jun; 14():92. PubMed ID: 27353492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial.
    Saadati S; Sadeghi A; Mansour A; Yari Z; Poustchi H; Hedayati M; Hatami B; Hekmatdoost A
    BMC Gastroenterol; 2019 Jul; 19(1):133. PubMed ID: 31345163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of vitamin D supplementation on liver fibrogenic factors in non-alcoholic fatty liver patients with steatohepatitis: study protocol for a randomized clinical trial.
    Ebrahimpour-Koujan S; Sohrabpour AA; Foroughi F; Alvandi E; Esmaillzadeh A
    Trials; 2019 Mar; 20(1):153. PubMed ID: 30832722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of alpha-lipoic acid on inflammatory markers and body composition in obese patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial.
    Hosseinpour-Arjmand S; Amirkhizi F; Ebrahimi-Mameghani M
    J Clin Pharm Ther; 2019 Apr; 44(2):258-267. PubMed ID: 30585337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pinitol consumption improves liver health status by reducing oxidative stress and fatty acid accumulation in subjects with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial.
    Lee E; Lim Y; Kwon SW; Kwon O
    J Nutr Biochem; 2019 Jun; 68():33-41. PubMed ID: 31030165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral coenzyme Q10 supplementation in patients with nonalcoholic fatty liver disease: effects on serum vaspin, chemerin, pentraxin 3, insulin resistance and oxidative stress.
    Farhangi MA; Alipour B; Jafarvand E; Khoshbaten M
    Arch Med Res; 2014 Oct; 45(7):589-95. PubMed ID: 25450583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of curcumin supplementation on expression of inflammatory transcription factors in hemodialysis patients: A pilot randomized, double-blind, controlled study.
    Alvarenga L; Salarolli R; Cardozo LFMF; Santos RS; de Brito JS; Kemp JA; Reis D; de Paiva BR; Stenvinkel P; Lindholm B; Fouque D; Mafra D
    Clin Nutr; 2020 Dec; 39(12):3594-3600. PubMed ID: 32204978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An energy-restricted high-protein diet supplemented with β-cryptoxanthin alleviated oxidative stress and inflammation in nonalcoholic fatty liver disease: a randomized controlled trial.
    Haidari F; Hojhabrimanesh A; Helli B; Seyedian SS; Ahmadi-Angali K
    Nutr Res; 2020 Jan; 73():15-26. PubMed ID: 31841744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Turmeric Supplementation Improves Serum Glucose Indices and Leptin Levels in Patients with Nonalcoholic Fatty Liver Diseases.
    Navekar R; Rafraf M; Ghaffari A; Asghari-Jafarabadi M; Khoshbaten M
    J Am Coll Nutr; 2017; 36(4):261-267. PubMed ID: 28443702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitamin D supplementation for the treatment of non-alcoholic fatty liver disease: A randomized double blind placebo controlled trial.
    Dabbaghmanesh MH; Danafar F; Eshraghian A; Omrani GR
    Diabetes Metab Syndr; 2018 Jul; 12(4):513-517. PubMed ID: 29588137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease.
    Faghihzadeh F; Adibi P; Rafiei R; Hekmatdoost A
    Nutr Res; 2014 Oct; 34(10):837-43. PubMed ID: 25311610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of green coffee extract supplementation on serum adiponectin concentration and lipid profile in patients with non-alcoholic fatty liver disease: A randomized, controlled trial.
    Hosseinabadi S; Rafraf M; Asghari S; Asghari-Jafarabadi M; Vojouhi S
    Complement Ther Med; 2020 Mar; 49():102290. PubMed ID: 32147076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is There a Role for Curcumin Supplementation in the Treatment of Non-Alcoholic Fatty Liver Disease? The Data Suggest Yes.
    Zabihi NA; Pirro M; Johnston TP; Sahebkar A
    Curr Pharm Des; 2017; 23(7):969-982. PubMed ID: 27748192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of phytosomal curcumin among patients with non-alcoholic fatty liver disease.
    Mirhafez SR; Rezai A; Dehabeh M; Nobakht M Gh BF; Bidkhori M; Sahebkar A; Hariri M
    Int J Vitam Nutr Res; 2021 Jun; 91(3-4):278-286. PubMed ID: 31818232
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.